REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 181 filers reported holding REGENXBIO INC in Q3 2021. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,606,549 | -12.5% | 583,630 | +6.3% | 0.04% | -12.5% |
| Q2 2023 | $10,977,108 | +29.7% | 549,130 | +22.6% | 0.04% | +25.0% |
| Q1 2023 | $8,466,574 | -14.6% | 447,730 | +2.4% | 0.03% | -11.1% |
| Q4 2022 | $9,914,108 | -46.8% | 437,130 | -38.1% | 0.04% | -54.4% |
| Q3 2022 | $18,652,000 | +7.0% | 705,730 | 0.0% | 0.08% | +12.9% |
| Q2 2022 | $17,431,000 | -24.6% | 705,730 | +1.3% | 0.07% | -7.9% |
| Q1 2022 | $23,112,000 | +19.6% | 696,365 | +17.8% | 0.08% | +18.8% |
| Q4 2021 | $19,327,000 | -18.9% | 591,060 | +4.0% | 0.06% | -27.3% |
| Q3 2021 | $23,821,000 | +55.8% | 568,268 | +44.4% | 0.09% | +57.1% |
| Q2 2021 | $15,290,000 | +34.5% | 393,568 | +18.1% | 0.06% | +14.3% |
| Q1 2021 | $11,371,000 | -30.2% | 333,390 | -7.2% | 0.05% | -37.2% |
| Q4 2020 | $16,292,000 | +496.1% | 359,190 | +261.6% | 0.08% | +457.1% |
| Q3 2020 | $2,733,000 | -14.2% | 99,343 | +14.8% | 0.01% | -22.2% |
| Q2 2020 | $3,186,000 | +11.6% | 86,508 | -1.9% | 0.02% | -5.3% |
| Q1 2020 | $2,856,000 | – | 88,208 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |